Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
AGTC Partners, L.P. (CIK 1419730) reported $13.6M across 2 reported positions in its SEC 13F filing for 2015-09-30. Largest positions: XLRN ($13.2M, 97.39%), BGMD ($354,000, 2.61%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | XLRN | Acceleron Pharma Inc. | $13.2M | 97.39% | 530,919 | Hold |
| 2 | BGMD | BG Medicine, Inc. | $354,000 | 2.61% | 863,269 | Trimmed |
Source: SEC Form 13F filings · as of 2015-09-30